---
title: "CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement Agent"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289967428.md"
description: "CEL-SCI completed a $2.5 million registered offering of 2,500,000 common shares at $1.00 per share on June 16, 2026, with ThinkEquity as placement agent. Net proceeds will fund Multikine development and general corporate purposes. The company incurred a 7% fee plus expenses up to $67,000. Lock-up agreements restrict share sales for 30 days for the company and 45 days for directors and officers."
datetime: "2026-06-16T21:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289967428.md)
  - [en](https://longbridge.com/en/news/289967428.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289967428.md)
generator: "portal-rs"
---

# CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement Agent

CEL-SCI entered into a Placement Agency Agreement with ThinkEquity for a registered offering of 2,500,000 common shares at $1.00 per share, generating $2.5 million in gross proceeds. The offering closed on June 16, 2026, with CEL-SCI paying a 7% placement fee and reimbursing expenses up to $67,000. Net proceeds will fund continued development of Multikine, general corporate purposes, and working capital. The company agreed to a 30-day issuance lock-up, and directors and officers agreed to 45-day lock-ups, subject to exceptions.

**Agreement details:**

-   **Agreement type**: Placement Agency Agreement for registered common stock offering
-   **Counterparty**: ThinkEquity
-   **Signed / Effective**: Jun 14 2026 / same
-   **Duration / Termination**: At will
-   **Reason**: Raise capital for Multikine and general corporate needs

Original SEC Filing: CEL SCI CORP \[ CVM \] - 8-K - Jun. 16, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CVM.US](https://longbridge.com/en/quote/CVM.US.md)

## Related News & Research

- [CEL-SCI CEO Geert Kersten acquires 100,000 common shares valued at $138,000](https://longbridge.com/en/news/297046035.md)
- [Cel-Sci GAAP EPS of -$0.47](https://longbridge.com/en/news/296114461.md)
- [Redegal: Strong revenue growth, AI-driven innovation, and expanding international presence define the outlook](https://longbridge.com/en/news/297273542.md)
- [PHX: Marketplace and analytics drove robust recurring growth, with margin expansion targeted for FY 2027](https://longbridge.com/en/news/297108945.md)
- [DIBS: Profitability and growth restored through tech-driven strategy and trusted luxury marketplace model](https://longbridge.com/en/news/297070483.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**